DE60020692D1 - Carbamoyltetrahydropyridin-derivate - Google Patents
Carbamoyltetrahydropyridin-derivateInfo
- Publication number
- DE60020692D1 DE60020692D1 DE60020692T DE60020692T DE60020692D1 DE 60020692 D1 DE60020692 D1 DE 60020692D1 DE 60020692 T DE60020692 T DE 60020692T DE 60020692 T DE60020692 T DE 60020692T DE 60020692 D1 DE60020692 D1 DE 60020692D1
- Authority
- DE
- Germany
- Prior art keywords
- group
- atom
- derivatives
- alkyl group
- carbamoyltetrahydropyridin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- KTXSODKVFJNBQU-UHFFFAOYSA-N 3,4-dihydro-2h-pyridine-1-carboxamide Chemical class NC(=O)N1CCCC=C1 KTXSODKVFJNBQU-UHFFFAOYSA-N 0.000 title abstract 2
- 125000006527 (C1-C5) alkyl group Chemical group 0.000 abstract 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 150000004944 pyrrolopyrimidines Chemical class 0.000 abstract 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 abstract 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000004414 alkyl thio group Chemical group 0.000 abstract 1
- 229910052801 chlorine Inorganic materials 0.000 abstract 1
- 125000001309 chloro group Chemical group Cl* 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 229910052740 iodine Inorganic materials 0.000 abstract 1
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Heart & Thoracic Surgery (AREA)
- Immunology (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Addiction (AREA)
- Hematology (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Diabetes (AREA)
- Rheumatology (AREA)
- Vascular Medicine (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP6500499 | 1999-03-11 | ||
JP6500499 | 1999-03-11 | ||
JP18562899 | 1999-06-30 | ||
JP18562899 | 1999-06-30 | ||
JP25835399 | 1999-09-13 | ||
JP25835399 | 1999-09-13 | ||
PCT/JP2000/001468 WO2000053604A1 (fr) | 1999-03-11 | 2000-03-10 | Derives de carbamoyl tetrahydropyridine |
Publications (2)
Publication Number | Publication Date |
---|---|
DE60020692D1 true DE60020692D1 (de) | 2005-07-14 |
DE60020692T2 DE60020692T2 (de) | 2006-03-23 |
Family
ID=27298632
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60020692T Expired - Fee Related DE60020692T2 (de) | 1999-03-11 | 2000-03-10 | Carbamoyltetrahydropyridin-derivate |
Country Status (11)
Country | Link |
---|---|
US (2) | US6600038B1 (de) |
EP (2) | EP1176146B1 (de) |
KR (1) | KR20010102544A (de) |
CN (1) | CN1174984C (de) |
AT (1) | ATE297393T1 (de) |
AU (1) | AU756702B2 (de) |
CA (1) | CA2366642A1 (de) |
DE (1) | DE60020692T2 (de) |
ES (1) | ES2239592T3 (de) |
HK (1) | HK1046683A1 (de) |
WO (1) | WO2000053604A1 (de) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR028782A1 (es) | 2000-07-05 | 2003-05-21 | Taisho Pharmaceutical Co Ltd | Derivados heterociclicos tetrahidropiridino o piperidino |
KR100867484B1 (ko) * | 2002-12-04 | 2008-11-06 | 에자이 알앤드디 매니지먼트 가부시키가이샤 | 1,3-디히드로이미다졸 축합 고리 화합물 |
AR042667A1 (es) * | 2002-12-26 | 2005-06-29 | Taisho Pharmaceutical Co Ltd | Derivados de pirrolopirimidina y pirrolopiridina sustituidos con un grupo amino ciclico |
US7030145B2 (en) | 2003-04-18 | 2006-04-18 | Bristol-Myers Squibb Company | Pyridinyl derivatives for the treatment of depression |
US7112585B2 (en) | 2003-04-18 | 2006-09-26 | Bristol-Myers Squibb Company | Pyrimidine derivatives as corticotropin releasing factor inhibitors |
ES2282986T3 (es) | 2004-01-06 | 2007-10-16 | Taisho Pharmaceutical Co., Ltd | Derivados de triaza-ciclopenta(cd)indeno. |
WO2005066142A2 (en) * | 2004-01-06 | 2005-07-21 | Taisho Pharmaceutical Co., Ltd. | Pyrrolopyrimidine and pyrrolotriazine derivatives as crf receptor antagonists |
CN1910190A (zh) * | 2004-01-06 | 2007-02-07 | 大正制药株式会社 | 环氨基取代的噻吩并嘧啶和噻吩并吡啶衍生物 |
RU2006135120A (ru) * | 2004-03-05 | 2008-04-10 | Тайсо Фармасьютикал Ко. | Производные пирролопиримидина |
JP2008503443A (ja) * | 2004-06-25 | 2008-02-07 | 大正製薬株式会社 | テトラヒドロピリジンで置換されたピロロピリミジン及びピロロピリジンの誘導体 |
JP2007161585A (ja) | 2004-06-25 | 2007-06-28 | Taisho Pharmaceut Co Ltd | 環状アミノ基で置換されているピロロピリミジン及びピロロピリジン誘導体 |
JP2008520749A (ja) * | 2004-11-23 | 2008-06-19 | レディ ユーエス セラピューティックス, インコーポレイテッド | 新規二環式ヘテロ環化合物、その調製のためのプロセス、およびその新規二環式ヘテロ環化合物を含む組成物 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2818676A1 (de) * | 1978-04-27 | 1979-11-08 | Troponwerke Gmbh & Co Kg | Substituierte 5,6-dimethylpyrrolo 2,3-d pyrimidine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
DE69323768T2 (de) * | 1992-12-17 | 1999-07-01 | Pfizer | Pyrrolopyrimidine als crf antagonisten |
DK0976745T3 (da) * | 1997-03-26 | 2003-10-27 | Taisho Pharmaceutical Co Ltd | 4-tetrahydropyridylpyrimidinderivat |
JPH11335376A (ja) | 1998-05-25 | 1999-12-07 | Taisho Pharmaceut Co Ltd | アリールテトラヒドロピリジン誘導体 |
JP2000086663A (ja) * | 1998-09-09 | 2000-03-28 | Taisho Pharmaceut Co Ltd | アリールテトラヒドロピリジン誘導体 |
-
2000
- 2000-03-10 AU AU29414/00A patent/AU756702B2/en not_active Ceased
- 2000-03-10 WO PCT/JP2000/001468 patent/WO2000053604A1/ja not_active Application Discontinuation
- 2000-03-10 EP EP00907999A patent/EP1176146B1/de not_active Expired - Lifetime
- 2000-03-10 CA CA002366642A patent/CA2366642A1/en not_active Abandoned
- 2000-03-10 ES ES00907999T patent/ES2239592T3/es not_active Expired - Lifetime
- 2000-03-10 CN CNB008074542A patent/CN1174984C/zh not_active Expired - Fee Related
- 2000-03-10 US US09/914,534 patent/US6600038B1/en not_active Expired - Fee Related
- 2000-03-10 KR KR1020017011455A patent/KR20010102544A/ko not_active Application Discontinuation
- 2000-03-10 AT AT00907999T patent/ATE297393T1/de not_active IP Right Cessation
- 2000-03-10 EP EP04005593A patent/EP1449843A1/de not_active Withdrawn
- 2000-03-10 DE DE60020692T patent/DE60020692T2/de not_active Expired - Fee Related
-
2002
- 2002-11-13 HK HK02108223A patent/HK1046683A1/xx not_active IP Right Cessation
-
2003
- 2003-01-21 US US10/347,288 patent/US6894168B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CA2366642A1 (en) | 2000-09-14 |
EP1176146B1 (de) | 2005-06-08 |
US20030191122A1 (en) | 2003-10-09 |
EP1176146A1 (de) | 2002-01-30 |
AU756702B2 (en) | 2003-01-23 |
CN1174984C (zh) | 2004-11-10 |
HK1046683A1 (en) | 2003-01-24 |
WO2000053604A1 (fr) | 2000-09-14 |
EP1449843A1 (de) | 2004-08-25 |
ES2239592T3 (es) | 2005-10-01 |
ATE297393T1 (de) | 2005-06-15 |
US6894168B2 (en) | 2005-05-17 |
US6600038B1 (en) | 2003-07-29 |
EP1176146A4 (de) | 2003-07-09 |
DE60020692T2 (de) | 2006-03-23 |
AU2941400A (en) | 2000-09-28 |
CN1350536A (zh) | 2002-05-22 |
KR20010102544A (ko) | 2001-11-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AP1753A (en) | Thiophene derivatives as antiviral agents for flavvivirus infection | |
NO20012617D0 (no) | Kinolin- og kinzolinderivater | |
ES2172864T3 (es) | 2-metoxibenzofenonas fungicidas. | |
BR9804214A (pt) | Compostos. | |
NO331013B1 (no) | Nye forbindelser som er anti-inflammasjons, immunomodulerende og anti-proliferative midler, anvendelse av forbindelsene samt farmasoytisk preparat | |
DE69418704D1 (de) | Anthranilsäure derivate | |
DK0862562T3 (da) | Benzoxazepinforbindelser, fremstilling deraf og anvendelse deraf som lipidniveauformindskende midler | |
DE60020692D1 (de) | Carbamoyltetrahydropyridin-derivate | |
EA200301142A1 (ru) | Производные гетероциклилокси-, -тиокси- и -аминобензазола в качестве лигандов 5-гидрокситриптамина-6 | |
PT718293E (pt) | Composto ciclodepsipeptidico | |
ATE452882T1 (de) | Herstellung von quetiapin | |
IL172290A0 (en) | Use of 2-amino-1-3-propanediol derivatives for the manufacture of a medicament for the treatment of various types of pain | |
NO20062202L (no) | Amidometylsubstituerte 2-(4-sulfonylamino)-3-hydroksy-3,4-dihydro-2H-kromen-6-yl-derivater, fremgangsmate og mellomprodukter for deres fremstilling, og legemidler som inneholder disse forbindelsene | |
BRPI0409376A (pt) | derivados de indeno como agentes farmacêuticos | |
PL326024A1 (en) | Novel derivatives of cyclodepsipeptidic substance pf1022 | |
HRP20050082A2 (en) | 6-amino-1h-indazole and 4-aminobenzofuran compounds as phosphodiesterase 4 inhibitors | |
DE60009905D1 (de) | Peroxycarbonsäure und ihre wässrigen zusammensetzungen | |
MXPA04007048A (es) | Derivados de amidoacetonitrilo. | |
HUP0302527A2 (hu) | Fungicid keverékek | |
DE69912193D1 (de) | Substituierte 2-Hydroxybenzophenone, ihre Herstellung, ihre Verwendung als fungizide und ihre fungizide Zusammensetzungen | |
ATE236901T1 (de) | Herbizide substituierte thienocycloalk(en)ylamino-1,3,5-triazine | |
EA200600115A1 (ru) | Производные 2-аминобензойной кислоты | |
GB0309440D0 (en) | Quinolone derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |